Lilienthal N et al., Immunokinase-based B-lymphotoxic delivery of activated DAPK1; Supplements from A Novel Recombinant Anti-CD22 Immunokinase Delivers Proapoptotic Activity of Death-Associated Protein Kinase (DAPK) and Mediates Cytotoxicity in Neoplastic B Cells
Nils Lilienthal, Marco Herling(TH Köln - University of Applied Sciences)
Cited by 0
Related Papers
CD4+/CD56+ Hematodermic Tumor
|American Journal of Clinical Pathology|2007|172
Actionable perturbations of damage responses by TCL1/ATM and epigenetic lesions form the basis of T-PLL
|Nature Communications|2018|105
JAK/STAT-Activating Genomic Alterations Are a Hallmark of T-PLL
|Cancers|2019|66